2023 Korean Association of Urogenital Tract Infection and Inflammation guidelines for gonococcal infection
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, Hee Jo | - |
dc.contributor.author | Lee, Hyuk Min | - |
dc.contributor.author | Lee, Seung-Ju | - |
dc.contributor.author | Choi, Jin Bong | - |
dc.contributor.author | Bae, Sangrak | - |
dc.contributor.author | Jung, Jae Hung | - |
dc.contributor.author | Kang, Tae Wook | - |
dc.contributor.author | Hwang, Eu Chang | - |
dc.date.accessioned | 2024-06-11T07:02:27Z | - |
dc.date.available | 2024-06-11T07:02:27Z | - |
dc.date.issued | 2024-01 | - |
dc.identifier.issn | 2466-0493 | - |
dc.identifier.issn | 2466-054X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/25940 | - |
dc.description.abstract | The incidence of gonorrhea has increased significantly in recent years in the United States, especially among sexually active twenty-year-olds. Although the incidence of gonorrhea has decreased in Korea since the early 2000s, it is still common among people in their twenties. Nucleic acid amplification test (NAAT) is the most sensitive diagnostic test for detecting gonococcal infection. Gram-staining is a simple and useful laboratory test for diagnosing symptomatic male gonococcal urethritis. Although bacterial culture can be used to detect antimicrobial susceptibility, its sensitivity is lower than that of NAAT. Treatment for uncomplicated gonorrhea infection is a single intramuscular injection of ceftriaxone 500 mg. Doxycycline (100 mg twice daily for 7 days) is added if there is a possibility of co-infection with chlamydia. If ceftriaxone is difficult to use, spectinomycin 2 g can be injected intramuscularly in Korea. Patients with gonorrhea should have repeated examinations within three months at the exposure site because of a high risk of re-infection. A person diagnosed with gonorrhea should discuss the nature of the infection, the importance of informing partners, when sexual activity can resume, and how to reduce the risk of sexually transmitted infections. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | KOREAN UROLOGICAL ASSOC | - |
dc.title | 2023 Korean Association of Urogenital Tract Infection and Inflammation guidelines for gonococcal infection | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.4111/icu.20230265 | - |
dc.identifier.scopusid | 2-s2.0-85182086919 | - |
dc.identifier.wosid | 001124884300001 | - |
dc.identifier.bibliographicCitation | INVESTIGATIVE AND CLINICAL UROLOGY, v.65, no.1, pp 1 - 8 | - |
dc.citation.title | INVESTIGATIVE AND CLINICAL UROLOGY | - |
dc.citation.volume | 65 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 8 | - |
dc.type.docType | Article; Early Access | - |
dc.identifier.kciid | ART003040281 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | RESISTANT NEISSERIA-GONORRHOEAE | - |
dc.subject.keywordPlus | CHLAMYDIA-TRACHOMATIS | - |
dc.subject.keywordPlus | CEFTRIAXONE | - |
dc.subject.keywordPlus | AZITHROMYCIN | - |
dc.subject.keywordPlus | CEFIXIME | - |
dc.subject.keywordPlus | RECOMMENDATIONS | - |
dc.subject.keywordPlus | SUSCEPTIBILITY | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | SAFETY | - |
dc.subject.keywordAuthor | Guideline | - |
dc.subject.keywordAuthor | Neisseria gonorrhoeae | - |
dc.subject.keywordAuthor | Sexually transmitted diseases | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.